Bell & Brown Wealth Advisors LLC acquired a new position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) in the 4th quarter, Holdings Channel reports. The fund acquired 41,600 shares of the company’s stock, valued at approximately $1,211,000. Several other hedge funds and other institutional investors also recently modified their holdings of RYTM. […]
NEA Management Company LLC reduced its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) by 0.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 4,909,956 shares of the company’s stock after selling 2,350 shares during the period. Rhythm Pharmaceuticals comprises about 8.0% of NEA Management Company LLC’s holdings, making the […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) dropped 10.2% during mid-day trading on Thursday . The company traded as low as $16.43 and last traded at $16.64. Approximately 490,412 shares changed hands during mid-day trading, a decline of 24% from the average daily volume of 645,541 shares. The stock had previously closed at $18.52. Analyst […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating)’s share price gapped down prior to trading on Tuesday following a weaker than expected earnings announcement. The stock had previously closed at $20.21, but opened at $18.84. Rhythm Pharmaceuticals shares last traded at $18.44, with a volume of 425,597 shares trading hands. The company reported ($0.92) earnings per […]